Researchers reviewed and summarized the safety and efficacy of individual antispasmodics available in North America for the treatment of chronic abdominal pain.
In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Researchers sought to determine what the impact and challenges of the opioid crisis were on pain treatments for patients with sickle cell disease.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.